America's Vital Interest in Global Health Protecting Our People, Enhancing Our Economy, and Advancing Our International Interests (1997) / Chapter Skim
Currently Skimming:
6: Advancing Our International Interests: Leading from Strength
6: Advancing Our International Interests: Leading from Strength
Pages 40-50
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 40... ...
The United States has the potential to lead global efforts for better health, but has yet to demonstrate its willingness to do so. This chapter sets out the rationale for a scientific response to global health challenges and the need for a strategic response involving the international health organizations and suggests some ways in which the United States might take the lead, with tremendous potential benefits for itself as well as for the rest of the world.
|
From page 41... ...
U.S. LEADERSHIP IN SCIENCE AND TECHNOLOGY The United States is currently the global leader in biomedical research.
|
From page 42... ...
Reproduced with permission. Another way in which the United States traditionally has led in science and technology for health is by training researchers and health professionals.
|
From page 43... ...
This section points to ways for the United States to help shape the future of these critically important institutions. The biggest overall change in the international health institutions in the past decade has been the growth in influence, both financial and intellectual, of the Bretton Woods institutions, while WHO's role appears to have been diminishing.
|
From page 44... ...
The United States must engage in biomedical research that will address major global health problems, such as the growing burdens of mental illness and cardiovascular disease and the continuing threat of infectious disease, through expanded partnerships and costsharing with other governments and international donors. Expanded investment in biomedical R&D by both the public and the private sectors is essential for the maintenance of U.S.
|
From page 45... ...
Training health professionals and researchers from the developing world in the United States would have other benefits as well. Health professionals who would return home with knowledge of state-of-the-science methods and medical technologies would be in a position to take scientific advances from the United States and make them relevant to their own countries.
|
From page 46... ...
Government. The United States should create a mechanism to bring together the authority and responsibility for coordinating activities of the many federal agencies contributing to global health activities, foster collaboration among them, and communicate policies and plans with other vested constituents, including the public.
|
From page 47... ...
Department of Health and Human Services because its unique scientific and technical expertise exemplified by NIH, Centers for Disease Prevention and Control, and Food and Drug Administration would enable it to coordinate global health strategy and the setting of priorities across the agencies represented in the task force and to act as the lead agency in establishing liaison with academia, NGOs, industry, and international agencies. The globalization of health problems, needs, and risks is a major international challenge and an extraordinary opportunity for the United States to work with other countries in a way that could significantly benefit the people of America and the world.
|
From page 48... ...
48 ._ a' it: Cal Cal Cal o Cal ._ ._ C)
|
From page 50... ...
allocate resources and specific authority to the U.S. Department of Health and Human Services because of its unique scientific and technical expertise, gained through institutions such as the National Institutes of Health and the Centers for Disease Control and Prevention to enable it to coordinate global health strategies and the setting of priorities across the agencies represented in the task force and to act as the lead agency in establishing liaison with academia, NGOs, industry, and the international agencies.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.